Cargando…
Assaying the Potency of Influenza Vaccines
The potency of vaccines must be determined to ensure that the appropriate dose is given. The manufacture and assessment of influenza vaccines are complicated by the continuously changing nature of the pathogen, which makes efficacy estimates difficult but also confounds attempts to produce a well-va...
Autor principal: | Minor, Philip D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494238/ https://www.ncbi.nlm.nih.gov/pubmed/26344948 http://dx.doi.org/10.3390/vaccines3010090 |
Ejemplares similares
-
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019) -
VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2018) -
Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies
por: Cheung, Chung Y., et al.
Publicado: (2022) -
An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
por: Bodle, Jesse, et al.
Publicado: (2023) -
Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays
por: Vasudevan, Anupama, et al.
Publicado: (2017)